Cyclic adenosine monophosphate inhibits ursolic acid-induced apoptosis via activation of protein kinase A in human leukaemic HL-60 cells

Pharmacology and Toxicology

Volumn 86, Issue 2, 2000, Pages 53-58

  Choi, Byung Min ^a,b   Park, Raekil ^a,b   Pae, Hyun Ock ^a,b   Yoo, Ji Chang ^a,b   Kim, Youn Chul ^b   Jun, Chang Duk ^a,b   Jung, Byung Hak ^b   Oh, Gi Su ^a,b   So, Hong Seob ^a,b   Kim, Young Myeong ^c   Chung, Hun Taeg ^a,b  

^a Wonkwang University School of Medicine   (South Korea)

^b 570 749   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; 8 BROMO CYCLIC AMP; BUCLADESINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DIMETHYL SULFOXIDE; DNA FRAGMENT; FORSKOLIN; KT 5720; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; RETINOIC ACID; SULFORHODAMINE B; URSOLIC ACID;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033983015     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2000.pto860201.x     Document Type: Article

References (27)

1. Arenas, M. J. & A. H. Wyllie: Apoptosis: mechanisms and roles in pathology. Int. Rev. Exp. Pathol. 1991, 32, 223-254.
2. Baek, J. H., Y. S. Lee, C. M. Kang, J. A. Kim, K. S. Kwon, H. C. Son & K. W. Kim: Intracellular Ca2+ release mediates ursolic acid-induced apoptosis in human leukemic HL-60 cells. Int. J. Cancer 1997, 73, 725-728.
3. Bilezikjian, L. M. & W. W. Vale: Stimulation of adenosine 3′,5′-monophosphate production by growth hormone-releasing factor and its inhibition by somatostatin in anterior pituitary cells in vitro. Endocrinology 1983, 113, 1726-1731.
4. Cha, H. J., S. K. Bae, H. Y. Lee, O. H. Lee, H. Sato, M. Seiki, B. C. Park & K. W. Kim: Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cancer Res. 1996, 56, 2281-2284.
5. Claffey, K. P., L. F. Brown, L. F. del Aguila, K. Tognazzi, K. T. Yeo, E. J. Manseau & H. F. Dvorak: Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cell incereases tumor growth, angiogenesis, and experimental metastasis. Cancer Res. 1996, 56, 172-181.
6. Daniel, V., G. Litwack & G. M. Tomkins: Induction of cytolysis of cultured lymphoma cells by adenosine 3′:5′-cyclic monophosphate and the isolation of resistant variants. Proc. Natl. Acad. Sci. USA 1973, 70, 76-79.
7. De, A., N. I. Boyadjieva, M. Pastorcic, B. V. Reddy & D. K. Sarkar: Cyclic AMP and ethanol interact to control apoptosis and differentiation in hypothalamic beta-endorphin neurons. J. Biol. Chem. 1994, 269, 26697-26705.
8. Gerschenson, L. E., & R. J. Rotello: Apoptosis: a different type of cell death. FASEB J. 1992, 6, 2450-2455.
9. Huang, M. T., C. T. Ho, Z. Y. Wang, T. Ferraro, Y. R. Lou, K. Stauber, W. Ma, C. Georgiadis, J. Laskin & A. H. Conney: Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res. 1994, 54, 701-708.
10. Kizaki, H., K. Suzuki, T. Tadakuma & Y. Ishimura: Adenosine receptor-mediated accumulation of cyclic AMP-induced T-lymphocyte death through internucleosomal DNA cleavage. J. Biol. Chem. 1990, 265, 5280-5284.
11. Krishan, A.: Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 1975, 66, 188-193.
12. Lee, H. Y., H. Y. Chung, K. H. Kim, J. J. Lee & K. W. Kim: Induction of differentiation in the cultured F9 teratocarcinoma stem cells by triterpene acids. J. Cancer Res. Clin. Oncol. 1994, 120, 513-518.
13. Lee, M. R., M. L. Liou, Y. F. Yang & M. Z. Lai: cAMP analogs prevent activation-induced apoptosis of T cell hybridomas. J. Immunol. 1993, 151, 5208-5284.
14. Maciejcwski, J., P. C. Selleri, T. Sato, H. J. Cho, L. K. Keefer & C. F. Nathan: Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. J. Clin. Invest. 1995, 96, 1085-1092.
15. Meitar, D., S. E. Crawford, A. W. Rademaker & S. L. Cohn: Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J. Clin. Oncol. 1996, 14, 405-414.
16. Ohigashi, H., H. Takamura, H. Koshimizu, H. Tokuda & Y. Ito: Search for possible antitumor promoters by inhibition of 12-0-tetradecanoylphorbol-13-acetate-induced Epstain-Bar virus activation: ursolic and oleanolic acid from an anti-inflammatory Chinese medical plant, Glechoma hederaceae L. Cancer Lett. 1986, 30, 143-151.
17. Olsson, I. L. &T. R. Breitman: Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3′:5′-monophosphate -inducing agents. Cancer Res. 1982, 42, 3924-3927.
18. Pratt, R. M. & G. R. Martin: Epithelial cell death and cyclic AMP increase during palatal development. Proc. Natl. Acad. Sci. USA 1975, 72, 874-877.
19. Rohlff, C., T. Clair & Y. S. Cho-chung: 8-Cl-cAMP induces truncation and down-regulation of the RI alpha subunit and up-regulation of the RII beta subunit of cAMP-dependent protein kinase leading to type II holoenzyme-dependent growth inhibition and differentiation of HL-60 leukemia cells. J. Biol. Chem. 1993, 268, 5774-5782.
20. Rydel, R. E. & L. A. Greene: cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor. Proc. Natl. Acad. Sci. USA 1988, 85, 1257-1261.
21. Schmidt, M. J., E. C. Palmer, W. D. Dettbarn & G. H. Robinson: Cyclic AMP and adenyl cyclase in the developing rat brain. Dev. Psychobiol. 1970, 3, 53-67.
22. Schwartzman, R. A. & J. A. Cidlowski: Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocrinol. Rev. 1993, 14, 133-151.
23. Sohn, K. H., H. Y. Lee, H. Y. Chung, H. S. Young, S. Y. Yi & K. W. Kim: Anti-angiogenic activity of triterpene acids. Cancer Lett. 1995, 94, 213-218.
24. Tokuda, H., H. Ohigashi, K. Koshimizu & Y. Ito: Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-tetsradecanoylphorbol-13-acetate. Cancer Lett. 1986, 33, 279-285.
25. Walker, C., F. Kristensen, F. Bettens & A. L. deWeek: Lymphokine regulation of activated (G1) lymphocytes. 1. Prostaglandin E2-induced inhibition of interleukin 2 production. J. Immunol. 1983, 130, 1770-1773.
26. Wyllie, A. H.: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980, 284, 555-556.
27. Zhu, W. H. & T. T. Loh: Roles of calcium in the regulation of apoptosis in HL-60 promyelocytic leukemia cells. Life Sci. 1995, 57, 2091-2099.